Affymetrix may not technically be a "new company," as one analyst recently called it, but its fourth quarter results revealed a firm with revenue growth driven by success in markets different from the ones it targeted just a few years ago.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
In Science this week: role for epigenetic in neuronal excitability, and more.
The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.
Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.
A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.